Yesterday, the Supreme Court of Canada issued an oral judgment at the hearing of Sanofi’s appeal in the ramipril Section 8 proceeding, dismissing the appeal with costs.
This proceeding was discussed in more detail in my post on Friday.
Update: The oral judgment has been published on the SCC’s website:
We are all of the view to dismiss the appeal substantially for the reasons of the majority of the Court of Appeal. The appeal is dismissed with costs.